Sen. Laura Fine

Filed: 3/16/2022





10200HB1780sam001LRB102 13555 CPF 37598 a


2    AMENDMENT NO. ______. Amend House Bill 1780 on page 4,
3line 1, by deleting "or"; and
4on page 4, by replacing line 3 with the following:
5    "required to perform kidney dialysis;
6        (11) drugs sold at retail as a unit dose package; or
7        (12) homeopathic drugs."; and
8on page 5, by replacing lines 20 and 21 with the following:
9    ""Proprietary information" means information that is:
10        (1) submitted under this Act;
11        (2) a trade secret or commercial or financial
12    information that is privileged or confidential and is
13    identified as such by the person providing the
14    information; and
15        (3) not required to be disclosed under any other law,
16    rule, or regulation affecting a covered drug, covered



10200HB1780sam001- 2 -LRB102 13555 CPF 37598 a

1    manufacturer, or pharmacy."; and
2on page 14, immediately below line 24, by inserting the
4    "The program promotion requirements under this Section do
5not apply to any drug take-back program established prior to
6the effective date of this Act that provides promotional or
7educational materials to the public about the proper
8collection and management of covered drugs."; and
9on page 18, line 6, by replacing "$5,000" with "$2,500".